Gastroenterology hospitalists (GIH) have become an integral to academic inpatient gastroenterology services, however the competencies and skills that distinguish GIH from non-GIH gastroenterologists are not yet well defined. The aim of this study was to compare the comfort level in performing inpatient-focused endoscopy skills by GIH and non-GIH.
Author: Abhay Panchal
A new social media platform exclusively for doctors launched this week. The free platform, called Roon, was founded by Vikram Bhaskaran and Arun Ranganathan, two former Pinterest leaders who serve as CEO and chief technology officer, respectively, as well as neurosurgeon Dr. Rohan Ramakrishna, who serves as the startup’s president. The platform is designed to address a growing gap in the physician community — its lack of a suitable space online to connect, debate and share clinical knowledge, Dr. Ramakrishna said. While AI tools like Anothropic’s Claude or OpenAI’s ChatGPT can do a good job of summarizing published literature, they…
A detailed Commonwealth Fund analysis shows that physician experiences with private equity vary dramatically depending on how deals are structured and whether doctors are treated as partners or employees. Some physicians reported that PE backing helped practices scale, invest in ancillary services, improve payer contracting, expand research participation, and reduce administrative burden. Others described declining compensation, growing management overhead, loss of autonomy, restrictive noncompete clauses, and increasing pressure to meet financial targets after acquisitions. The report highlights that PE-backed consolidation is rapidly expanding across specialties including urology, orthopedics, OB/GYN, anesthesiology, and gastroenterology. While supporters argue these partnerships help independent practices…
Private equity firms are increasingly being forced to rethink their healthcare strategies as scrutiny around physician practice roll-ups and consolidation intensifies. According to investor Matthew Bennett of Invidia Capital Management, many large physician roll-up models struggled because they expanded too aggressively, failed to integrate practices effectively, and could not clearly demonstrate improvements in care quality or cost reduction. As a result, investor sentiment is shifting away from pure consolidation-driven strategies. Instead, firms are becoming more selective and increasingly focused on businesses that can show measurable operational or clinical improvements, particularly through technology, interoperability, workflow efficiency, and lower-cost care delivery. Bennett…
An experimental drug called daraxonrasib is generating major excitement in pancreatic cancer after early trials showed it could significantly extend survival in advanced disease. The drug targets RAS, a protein long considered “undruggable” and mutated in more than 90% of pancreatic cancers. In a Phase 3 study, patients receiving daraxonrasib plus chemotherapy had median survival of 13.2 months compared with 6.7 months for chemotherapy alone. Earlier-stage data published in the New England Journal of Medicine also showed prolonged disease control and survival in metastatic pancreatic cancer. Researchers and oncologists described the therapy as one of the most significant advances in…
A growing message in gastroenterology is that nutrition should no longer be treated as an “adjunct” to care, but as a core clinical intervention. In a Medscape commentary, gastroenterologist Alicia Muratore, MD, argues that GI specialists already use nutrition therapeutically across conditions like IBD, IBS, MASLD, celiac disease, and gastroparesis—but often fail to fully integrate or “own” those discussions in practice. She highlights growing evidence supporting nutrition-based interventions, including weight loss reversing fibrosis in MASLD and exclusive enteral nutrition matching steroids in pediatric Crohn’s disease.
Routine mental health screening in IBD clinics may significantly improve patient engagement with psychogastroenterology care, according to data presented at Digestive Disease Week 2026. In a University of Chicago study, a single IBD specialist who integrated PHQ-9 and GAD-7 screening into routine visits generated the highest number of psychogastroenterology referrals and significantly better follow-up rates compared with clinics without embedded screening. The findings reinforce the growing role of integrated, team-based care in IBD, where mental health support is increasingly viewed as a core component of disease management rather than a separate service.
An AI-based endoscopic scoring system developed by Johnson & Johnson may significantly improve efficiency in ulcerative colitis clinical trials by detecting treatment effects more sensitively than traditional scoring methods. Presented at Digestive Disease Week 2026, the ARGES-UC platform uses continuous AI-generated scoring from endoscopy videos rather than conventional category-based Mayo scores. In a phase 2b UC trial, the system demonstrated larger treatment effect sizes and reduced estimated trial sample size requirements by up to 47%, potentially enabling smaller, faster, and less costly studies. Researchers emphasized that the technology is currently aimed at improving clinical trial design rather than replacing standard…
Neptune Medical reported positive first-in-human results for its Triton Robotic Endoscopy system, with a 50-patient study showing no adverse events and 100% cecal intubation during colonoscopy procedures. The robotic platform is designed to improve scope control, stability, and ergonomics compared to traditional manual colonoscopy. Investigators also reported high adenoma and polyp detection rates, successful removal of all polyps under 2 cm, and significantly lower physical and mental workload for endoscopists. The company says the system aims to combine robotic navigation with future AI-assisted detection capabilities to support more consistent, high-quality colonoscopy regardless of operator experience.
Olympus has partnered with EndoRobotics to globally distribute robot-assisted technologies for advanced endoscopic procedures, with an initial focus on the U.S. market. The collaboration is aimed at expanding adoption of technically demanding procedures like endoscopic submucosal dissection (ESD), which are increasingly important for treating early-stage GI cancers and precancerous lesions. Olympus said the partnership aligns with its broader strategy to combine robotics, AI, and minimally invasive endoscopy to improve procedural precision, efficiency, and patient access to advanced GI therapies.